Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

Yasutomo Nasu, Terry L. Timme, Guang Yang, Chris H. Bangma, Likun Li, Chengzhen Ren, Sang Hee Park, Marlene DeLeon, Jianxiang Wang, Timothy C. Thompson

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

Although prostate cancer cells are often initially sensitive to androgen ablation, they eventually lose this response and continue to survive, grow and spread in the absence of androgenic steroids. The mechanism(s) that underlie resistance to androgen ablation therapy remain mostly unknown. We have demonstrated that elevated caveolin protein levels are associated with human prostate cancer progression in pathological specimens. Here we show that suppression of caveolin expression by a stably transfected antisense caveolin-1 cDNA vector converted androgen-insensitive metastatic mouse prostate cancer cells to an androgen-sensitive phenotype. Orthotopically grown tumors and low-density cell cultures derived from antisense caveolin clones had increased apoptosis in the absence of androgenic steroids, whereas similarly grown tumors and cells from vector (control) clones and parental cells were not sensitive to androgens. Studies using a representative antisense caveolin clone showed that selection for androgen resistance in vivo correlated with increased caveolin levels, and that adenovirus-mediated caveolin expression blocked androgen sensitivity. Our results identify a new candidate gene for hormone-resistant prostate cancer in man and indicate that androgen insensitivity can be an inherent property of metastatic prostate cancer.

Original languageEnglish
Pages (from-to)1062-1064
Number of pages3
JournalNature Medicine
Volume4
Issue number9
DOIs
Publication statusPublished - Sep 1998
Externally publishedYes

Fingerprint

Caveolins
Androgens
Prostatic Neoplasms
Cells
Clone Cells
Ablation
Tumors
Steroids
Caveolin 1
Cell culture
Adenoviridae
Neoplasms
Complementary DNA
Cell Culture Techniques
Genes
Hormones
Apoptosis
Phenotype

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. / Nasu, Yasutomo; Timme, Terry L.; Yang, Guang; Bangma, Chris H.; Li, Likun; Ren, Chengzhen; Park, Sang Hee; DeLeon, Marlene; Wang, Jianxiang; Thompson, Timothy C.

In: Nature Medicine, Vol. 4, No. 9, 09.1998, p. 1062-1064.

Research output: Contribution to journalArticle

Nasu, Y, Timme, TL, Yang, G, Bangma, CH, Li, L, Ren, C, Park, SH, DeLeon, M, Wang, J & Thompson, TC 1998, 'Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells', Nature Medicine, vol. 4, no. 9, pp. 1062-1064. https://doi.org/10.1038/2048
Nasu, Yasutomo ; Timme, Terry L. ; Yang, Guang ; Bangma, Chris H. ; Li, Likun ; Ren, Chengzhen ; Park, Sang Hee ; DeLeon, Marlene ; Wang, Jianxiang ; Thompson, Timothy C. / Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. In: Nature Medicine. 1998 ; Vol. 4, No. 9. pp. 1062-1064.
@article{c7c5a04821b7424fa9c98c67a88c46a3,
title = "Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells",
abstract = "Although prostate cancer cells are often initially sensitive to androgen ablation, they eventually lose this response and continue to survive, grow and spread in the absence of androgenic steroids. The mechanism(s) that underlie resistance to androgen ablation therapy remain mostly unknown. We have demonstrated that elevated caveolin protein levels are associated with human prostate cancer progression in pathological specimens. Here we show that suppression of caveolin expression by a stably transfected antisense caveolin-1 cDNA vector converted androgen-insensitive metastatic mouse prostate cancer cells to an androgen-sensitive phenotype. Orthotopically grown tumors and low-density cell cultures derived from antisense caveolin clones had increased apoptosis in the absence of androgenic steroids, whereas similarly grown tumors and cells from vector (control) clones and parental cells were not sensitive to androgens. Studies using a representative antisense caveolin clone showed that selection for androgen resistance in vivo correlated with increased caveolin levels, and that adenovirus-mediated caveolin expression blocked androgen sensitivity. Our results identify a new candidate gene for hormone-resistant prostate cancer in man and indicate that androgen insensitivity can be an inherent property of metastatic prostate cancer.",
author = "Yasutomo Nasu and Timme, {Terry L.} and Guang Yang and Bangma, {Chris H.} and Likun Li and Chengzhen Ren and Park, {Sang Hee} and Marlene DeLeon and Jianxiang Wang and Thompson, {Timothy C.}",
year = "1998",
month = "9",
doi = "10.1038/2048",
language = "English",
volume = "4",
pages = "1062--1064",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells

AU - Nasu, Yasutomo

AU - Timme, Terry L.

AU - Yang, Guang

AU - Bangma, Chris H.

AU - Li, Likun

AU - Ren, Chengzhen

AU - Park, Sang Hee

AU - DeLeon, Marlene

AU - Wang, Jianxiang

AU - Thompson, Timothy C.

PY - 1998/9

Y1 - 1998/9

N2 - Although prostate cancer cells are often initially sensitive to androgen ablation, they eventually lose this response and continue to survive, grow and spread in the absence of androgenic steroids. The mechanism(s) that underlie resistance to androgen ablation therapy remain mostly unknown. We have demonstrated that elevated caveolin protein levels are associated with human prostate cancer progression in pathological specimens. Here we show that suppression of caveolin expression by a stably transfected antisense caveolin-1 cDNA vector converted androgen-insensitive metastatic mouse prostate cancer cells to an androgen-sensitive phenotype. Orthotopically grown tumors and low-density cell cultures derived from antisense caveolin clones had increased apoptosis in the absence of androgenic steroids, whereas similarly grown tumors and cells from vector (control) clones and parental cells were not sensitive to androgens. Studies using a representative antisense caveolin clone showed that selection for androgen resistance in vivo correlated with increased caveolin levels, and that adenovirus-mediated caveolin expression blocked androgen sensitivity. Our results identify a new candidate gene for hormone-resistant prostate cancer in man and indicate that androgen insensitivity can be an inherent property of metastatic prostate cancer.

AB - Although prostate cancer cells are often initially sensitive to androgen ablation, they eventually lose this response and continue to survive, grow and spread in the absence of androgenic steroids. The mechanism(s) that underlie resistance to androgen ablation therapy remain mostly unknown. We have demonstrated that elevated caveolin protein levels are associated with human prostate cancer progression in pathological specimens. Here we show that suppression of caveolin expression by a stably transfected antisense caveolin-1 cDNA vector converted androgen-insensitive metastatic mouse prostate cancer cells to an androgen-sensitive phenotype. Orthotopically grown tumors and low-density cell cultures derived from antisense caveolin clones had increased apoptosis in the absence of androgenic steroids, whereas similarly grown tumors and cells from vector (control) clones and parental cells were not sensitive to androgens. Studies using a representative antisense caveolin clone showed that selection for androgen resistance in vivo correlated with increased caveolin levels, and that adenovirus-mediated caveolin expression blocked androgen sensitivity. Our results identify a new candidate gene for hormone-resistant prostate cancer in man and indicate that androgen insensitivity can be an inherent property of metastatic prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0031665843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031665843&partnerID=8YFLogxK

U2 - 10.1038/2048

DO - 10.1038/2048

M3 - Article

C2 - 9734401

AN - SCOPUS:0031665843

VL - 4

SP - 1062

EP - 1064

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 9

ER -